DTSQ Purchaser Inc.
DTSQ Purchaser Inc. (a SPAC subsidiary of DT Cloud Star Acquisition Corp., Nasdaq: DTSQ) filed an S-4 registration statement for its proposed business combination with PrimeGen US, Inc., a Delaware biotech company. The deal values PrimeGen at $1,489,800,000, with PGUS stockholders receiving 105,687,444 shares of Pubco Common Stock as Merger Consideration based on a Redemption Price of $11.05. The transaction involves a Redomestication Merger (DTCS merging into a Delaware corporation) followed by an Acquisition Merger, with Pubco to be renamed "PrimeGen Holdings, Inc." and listed on Nasdaq.
- Purchase price of $1,489,800,000, with 105,687,444 shares of Pubco Common Stock as Merger Consideration based on $11.05 Redemption Price.
- 76.05% of public shares (5,247,491 shares) were redeemed at the October 2025 extension vote, leaving ~$18.3M in trust.
- Sponsor receives $2,500,000 Sponsor Closing Payment plus 250,000 DTCS Ordinary Shares at closing.
- Non-redeeming shareholders receive pro-rata Pubco Non-Redemption Warrants (1,931,900 total) with $2.00 strike, exercisable for 18 months.
- Outside Date is October 26, 2026, extendable by mutual agreement to January 26, 2027.
Price data unavailable.
A $1.49B biotech de-SPAC with a trust already depleted to ~$18.3M after 76% redemptions, testing whether non-redemption warrant incentives can preserve enough cash to close.
SPAC market remains challenged with elevated redemption rates; this de-SPAC follows the pattern of non-redemption incentive structures (warrants) to retain public float. PrimeGen US operates in the biotech space (SIC 2836), a sector where SPAC combinations have faced post-close volatility.
High redemption risk: 76% of public shares already redeemed at the extension vote, leaving only ~$18.3M in trust. If redemptions at the business combination vote are substantial, the combined company may lack sufficient cash. Nasdaq listing approval is not guaranteed and is a closing condition; if D
Get filings like this before the market reacts.
Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.